Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor

Written By :  Dr Akhil Kapoor
Published On 2025-08-21 06:45 GMT   |   Update On 2025-08-21 08:53 GMT
Advertisement
In this video, Dr. Akhil Kapoor, Medical Oncologist at Tata Memorial Centre, Varanasi, Uttar Pradesh, discusses a real-world case study of chemotherapy-induced anemia in advanced breast cancer. The case features a 63-year-old woman diagnosed with HER2-positive metastatic breast cancer, who was started on standard chemotherapy with paclitaxel, trastuzumab, and pertuzumab. While chemotherapy is widely used for cancer, it often leads to side effects such as anemia, which can severely impact a patient’s quality of life.
Dr. Kapoor highlights how darbepoetin alfa, an erythropoiesis-stimulating agent, played a crucial role in managing her chemotherapy-induced anemia by improving hemoglobin levels. Watch the full video to gain clinical insights into the use of darbepoetin alfa in breast cancer management and its role in improving patient outcomes in real-world oncology practice.
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News